CX Partners is investing upto R200Cr in Bangalore based Sutures India for a 40% stake. According to ToI,CX Partners will buyout Evolvence Life Sciences Fund's stake and may also buy part of the promoter's stake in the company. The deal is subject to FIPB approval.
Zodius Capital has closed first tranche of its second fund Zodius Capital II at R700 Cr ($110 Mn). The $500 Mn fund was launched in last year along with Alternate Asset Management, a subsidiary of Avendus Capital.